MEIBOMIAN GLAND DYSFUNCTION

This study tested an eyedrop called TP-03 in 39 people with dry eye disease caused by Demodex mites. The goal was to see if giving the drops twice or three times a day is safe and works better. The study focused on safety and how well the drops improve signs of the condition.

This study tested three ways to treat meibomian gland dysfunction (MGD), a common cause of dry eye. 374 adults with mild-to-moderate MGD received either a warm compress mask, a device that pulses heat and massages the eyelids, or light therapy combined with gland expression. The …

This study tested the TearCare system, a device that applies heat to the eyelids to unblock oil glands, in 235 adults with dry eye disease. The goal was to see if it safely improves tear quality and eye comfort compared to another device called LipiFlow. The trial measured change…

This study tested a special laser (micropulse) to treat dry eye caused by meibomian gland dysfunction. The laser targets abnormal blood vessels on the eyelid edge to reduce inflammation. 30 adults with moderate to severe dry eye were enrolled. The goal was to see if this treatmen…

This study tested if using the Systane iLux system, a device that applies heat and pressure to the eyelids, can improve dry eye symptoms in people about to have cataract surgery. Thirty adults with dry eye due to meibomian gland dysfunction took part. The goal was to see if the t…

This study tested whether a device called TearCare, which applies heat to the eyelids, is safe and works better than Restasis eye drops for treating dry eye disease. 345 adults with dry eye and blocked oil glands took part. The main goals were to see if TearCare improved tear sta…

This study looked at how two light-based treatments—intense pulsed light (IPL) and low-level light therapy (LLLT)—help people with dry eye and clogged oil glands in the eyelids. 26 adults received four treatment sessions, with one eye getting both therapies and the other getting …